ArticleThe ISME journal2025
Halobacteriovorax halts disease progression in endangered Caribbean corals.
Article in The ISME journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Symbiont Identity Impacts Prokaryotic Microbiome Dynamics During Heat Stress in a Model System for Corals.Integrative and comparative biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Predation is a top-down regulator of ecosystem integrity and a key driver of community structure and evolution in plants and animals. Despite our awareness of these dynamics, our understanding of microbial top-down control by bacterial predators remains limited. Predatory Halobacteriovorax bacteria are common, low abundance members of many marine and estuarine microbiomes and are considered generalists with less specific prey ranges than most viruses, yet more selective targets than antibiotics. This "Goldilocks" prey range has huge potential to treat polymicrobial infections, particularly in complex microbiomes; however, few studies employing Halobacteriovorax as a tool to manipulate dysbiotic microbiomes have been pursued. We developed a single-pathogen disease mitigation model in the critically endangered Caribbean coral, Acropora cervicornis. We employed a strain of the highly versatile Vibrio coralliilyticus as our pathogen, which causes rapid tissue loss and death in stony corals and mortality in oyster larvae. To demonstrate that predatory bacteria can alter disease dynamics in corals we infected A. cervicornis with virulent V. coralliilyticus and upon the first signs of disease, treated corals with Halobacteriovorax cultures. Without predators, 100% of corals were bleached by 48 h and 86% displayed tissue loss within five days; however with Halobacteriovorax, 57% of corals did not bleach beyond the inoculation site and no tissue loss was observed. This living probiotic successfully halted Vibrio-induced disease progression in A. cervicornis, suggesting that predatory bacteria broadly function as top-down regulators of community dynamics in eukaryotic microbiomes and microbial predators are a promising coral disease therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.